Please login to the form below

Not currently logged in
Email:
Password:

ALS

This page shows the latest ALS news and features for those working in and with pharma, biotech and healthcare.

Novartis buys gene therapy firm AveXis for $8.7bn

Novartis buys gene therapy firm AveXis for $8.7bn

Rett syndrome and inherited amyotrophic lateral sclerosis (ALS) that are scheduled to start trials in late 2018 or early 2019.

Latest news

More from news
Approximately 12 fully matching, plus 91 partially matching documents found.

Latest Intelligence

  • The Patient Safety Challenge The Patient Safety Challenge

    care. We have, for many years, worked with Dr Moza Al Hail, the executive director of pharmacy, and her colleagues within the health service in Qatar.

  • The cultural construction of illness The cultural construction of illness

    Why understanding this concept is  essential for pharmaceutical marketers

  • Perfecting the pharmaceutical pipeline with AI Perfecting the pharmaceutical pipeline with AI

    In fact, this has helped our team of scientists at BenevolentBio establish a set of hypotheses for drug candidates for Amyotrophic Lateral Sclerosis (ALS), a form of Motor Neurone Disease. ... Together with the Sheffield Institute of Translational

  • Rare diseases: meeting the challenge Rare diseases: meeting the challenge

    SKC’s white paper ‘Orphan Drugs in Germany - lessons learned from AMNOG, best and worst practices and strategic implications’ (Kirchmann et al, 2017) offers pharma manufacturers a few pointers for successful

  • Deal Watch November 2016 Deal Watch November 2016

    This does not typically include royalty payments. 2. Ataga et al, Abstract, American Society of Hematology (ASH), December 2016.

More from intelligence
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 23 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anthill Agency

Anthill is a specialist digital agency and a strategic partner for life science companies....

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics